Skip to content

Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs

Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04373759
Acronym
ACICOVID
Enrollment
186
Registered
2020-05-04
Start date
2020-05-02
Completion date
2020-09-30
Last updated
2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19, Sars-CoV2

Keywords

novel coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Out-of-hospital cardiac arrest, In-hospital cardiac arrest, unexpected cardiac arrest, Intensive care unit

Brief summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the novel coronavirus disease 2019 (COVID-19) pandemic. Among COVID-19 complications, in-hospital cardiac arrest (IHCA) was reported with a very poor outcome in a retrospective single-center study (0,7% of 30 days survival with good neurological outcome among IHCA patients with a resuscitation attempt), related to its natural course and management. The incidence of unexpected in-ICU cardiac arrest (ICUCA) due to COVID-19 is still unknown. Additionally, outcome of COVID-19 patients admitted in ICU for an out-of-hospital cardiac arrest (OHCA) is also undescribed. The objective this study is : * to report the incidence of ICUCA among patients hospitalized in French ICU for COVID-19. * to report morbidity and mortality among COVID-19 patients admitted alive in ICU for an OHCA or an IHCA. The secondary objective is to assess outcome and identify risk factors of ICUCA occurrence among patients admitted for COVID-19.

Detailed description

Retrospective and prospective multicentric observational registry in French intensive care units (ICU) including all consecutive adult patients admitted in ICU with a documented SARS-CoV-2 disease : * For an out-of-hospital or an in-hospital cardiac arrest (OHCA and IHCA respectively) * Or presenting an unexpected in-ICU cardiac arrest (ICUCA) Patients characteristics, cardiac arrest history and patients outcome will be recorded according to Utstein recommendations. Patients presenting an expected cardiac arrest in ICU related to withdrawal of life sustaining therapies (WLST) will be excluded.

Interventions

OTHERCardiopulmonary resuscitation

Cardiopulmonary resuscitation

OTHERModified Rankin score

0 - no symptoms at all 1. \- no significant disability despite symptoms; able to carry out all usual duties and activities 2. \- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance 3. \- Moderate disability; requiring some help, but able to walk without assistance 4. \- Moderately severe disability; unable to walk and attend to bodily needs without assistance 5. \- Severe disability; bedridden, incontinent and requiring constant nursing care and attention 6. \- Dead

Sponsors

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients admitted in intensive care unit with a documented SARS-CoV-2 disease * For an out-of-hospital or an in-hospital cardiac arrest * Or an in-hospital cardiac arrest * Or presenting an unexpected in-intensive care unit cardiac arrest

Exclusion criteria

* Age under 18 y.o * Expected in-intensive care unit cardiac arrest related to withdrawal of life sustaining therapies. * Withdrawal of patient or next-of-kin informed consent

Design outcomes

Primary

MeasureTime frameDescription
Incidence of unexpected cardiac arrest7 monthsPercentage of unexpected in-intensive care unit cardiac arrest among COVID-19 patients admitted to intensive care unit

Secondary

MeasureTime frameDescription
Charlson score7 monthsDiabetes, hypertension, smoking, dyslipidemia, coronary artery disease, chronic respiratory insufficiency, chronic heart failure, chronic renal insufficiency, chronic hepatic insufficiency, chronic neurological disease, cancer, malignant hemopathy. Charlson score's minimum and maximum values are 0 and 40 respectively, the lowest score corresponds to a better outcome.
Organ failure score at ICU admission and/or before unexpected in-ICU cardiac arrest7 monthsRespiratory failure, neurological impairment, circulatory failure, hepatic failure, haematological failure, renal failure. Sofa score's minimum and maximum values are 0 and 24, the lowest score corresponds to a better outcome
Etiology retained to explain cardiac arrest occurrence7 monthsCardiac origin; Respiratory origin; Metabolic origin; unknown origin
Modified Rankin score (mRS) at ICU discharge, at hospital discharge and at 3 months3 months0 - no symptoms at all 1. \- no significant disability despite symptoms; able to carry out all usual duties and activities 2. \- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance 3. \- Moderate disability; requiring some help, but able to walk without assistance 4. \- Moderately severe disability; unable to walk and attend to bodily needs without assistance 5. \- Severe disability; bedridden, incontinent and requiring constant nursing care and attention 6. \- Dead

Countries

France, Martinique

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026